ArticleCancer biomarkers : section A of Disease markers2019

The ratio of Bcl-2/Bim as a predictor of cisplatin response provides a rational combination of ABT-263 with cisplatin or radiation in small cell lung cancer.

Hong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.